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OBJECTIVES This study sought to assess the role of tumor necrosis factor- (TNF-) in myocardial
ischemia/reperfusion (I/R) injury using TNF- knockout (KO) mice.
BACKGROUND Tumor necrosis factor- is thought to be involved in the pathogenesis of myocardial I/R
injury by promoting leukocyte infiltration of the myocardium. However, the precise role of
TNF- in I/R injury is still unknown.
METHODS The hearts in TNF- KO and wild-type (WT) mice were exposed by left lateral thoracotomy,
and the left coronary artery was occluded for 30 min then reperfused for 120 min.
RESULTS The infarct size in TNF- KO mice was significantly reduced compared with WT mice. The
frequency of arrhythmia was decreased, and cardiac function during reperfusion was
significantly improved in TNF- KO mice compared with WT mice. The activation of
nuclear factor-B (NF-B), the expression of chemokines and adhesion molecules and the
infiltration of leukocytes were also significantly reduced in TNF- KO mice, compared with
WT mice. These findings provide evidence that TNF- aggravates I/R injury.
CONCLUSIONS Tumor necrosis factor- exacerbates myocardial I/R injury at an early stage of reperfusion by
activating NF-B, thereby inducing chemokines and adhesion molecules and facilitating
leukocyte infiltration. (J Am Coll Cardiol 2002;39:1229–35) © 2002 by the American
College of Cardiology Foundation
Recanalization of occluded coronary arteries is a standard
method of treatment for acute myocardial infarction. How-
ever, reperfusion itself can cause myocardial damage, which
is designated as ischemia/reperfusion (I/R) injury. Numer-
ous studies have demonstrated that leukocyte infiltration
occurs in the reperfused myocardium (1). Leukocytes, espe-
cially polymorphonuclear neutrophils, mediate the damage
to endothelial cells and cardiac myocytes during reperfusion.
Tumor necrosis factor- (TNF-) is known to be a
proinflammatory cytokine. Recent studies have demon-
strated that TNF- is produced during I/R injury (2,3) and
activates nuclear factor-B (NF-B), which initiates the
cytokine cascade and facilitates the expression of chemo-
kines and adhesion molecules. Treatment with anti-TNF-
antibody has been reported to improve myocardial recovery
after I/R (4).
In contrast, beneficial effects of TNF- on acute myo-
cardial infarction (5) have also been reported, where TNF-
receptor knockout (KO) mice show accelerated myocardial
apoptosis after ischemia, indicating that TNF- has a
protective action against ischemia. Accordingly, it is impor-
tant to reevaluate the effects of TNF- on myocardial I/R
injury using TNF- KO.
METHODS
Animals. Tumor necrosis factor- KO mice were gener-
ated by gene targeting, as described previously (6).
C57BL/6J mice were used as wild-type (WT) controls.
Male mice at 12 to 13 weeks of age were used for this
experiment, which was performed according to the “Posi-
tion of the American Heart Association on Research Ani-
mal Use,” adopted by the American Heart Association
November 11, 1984.
Surgical procedures. Mice were anesthetized with 2%
halothane (Takeda Pharmaceutical, Osaka, Japan) and 40%
oxygen, and maintained with 0.5% halothane and 40%
oxygen. Tracheotomy was performed to provide artificial
ventilation (0.3 ml tidal volume, 120 breaths/min), and the
left coronary artery was ligated with an 8-0 nylon surgical
suture 1.0 mm distal from tip of the left auricle.
Measurements of infarct area and area at risk. After
30-min ligation and 120-min reperfusion, the left coronary
artery was reoccluded at the same point and Evans blue dye
was perfused from the left ventricular (LV) cavity. The heart
was removed and cut transversely into five sections, which
were then incubated in a 1.0% solution of 2,3,5-triphenyl-
tetrazolium chloride (TTC; Sigma, St. Louis, Missouri) for
20 min at 37°C. The area at risk (AAR) and the infarct area
(IA) corresponded to the area unstained with Evans blue
dye and the area unstained with TTC solution, respectively.
Each slice of the ventricle was weighed, and the AAR to LV
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ratio and IA to LV ratio of each slice were determined using
National Institutes of Health Image version 1.62.
Neutralization of TNF- with a selective antibody. To
neutralize the action of TNF- in WT mice, 10 g of goat
anti-mouse TNF- polyclonal antibody (AF-410-NA;
R&D Systems Inc., Minneapolis, Minnesota) dissolved in
0.1 ml of saline was injected through the tail vein 30 min
before left coronary artery ligation.
Electrocardiogram monitoring of arrhythmia. Electro-
cardiogram recording started 10 min before occlusion and
continued until the end of reperfusion (160 min total). Data
were sampled at a rate of 10 kHz and analyzed using
MacLab/8s (AD Instruments, Castle Hill, Australia).
Hemodynamic study. A 1.4 French high-fidelity catheter
tip micromanometer (SPR-671; Millar Instruments, Hous-
ton, Texas) was inserted through the right carotid artery
into the LV cavity to measure LV pressure. First derivative
of LV pressure (dP/dt) was analyzed using MacLab/8s.
Electrophoretic gel mobility shift assay. Nuclear extract
was prepared from the entire LV of the reperfused heart
according to the method described by Morishita et al. (7).
Nuclear extract was incubated with 1  105 cpm 32P-
labeled oligonucleotide containing the NF-B consensus
sequences (Promega Corp., Madison, Wisconsin). The
protein content was measured, and 10 g of protein was
applied to each lane.
RNA extraction, reverse transcription and polymerase
chain reaction analysis. Total RNA was extracted from
ischemic and nonischemic regions. Reverse transcription
(RT) and real-time quantitative polymerase chain reaction
(PCR) were performed using a Light Cycler (F. Hoffmann-
LaRoche Ltd., Basel, Switzerland). The expression levels of
TNF-, interleukin (IL)-6, intercellular adhesion molecule
(ICAM)-1, vascular cell adhesion molecule-1, macrophage
Figure 1. Arrhythmia observed during myocardial ischemia/reperfusion.
(A) Summarized data on the arrhythmia during reperfusion in wild-type
(n 11) and tumor necrosis factor (TNF)- knockout (KO) (n 9) mice.
(B) Summarized data on the arrhythmia during reperfusion in wild-type
mice receiving nonimmune IgG (n  5) and anti-TNF- antibody (n 
5). **p  0.01.
Figure 2. Hemodynamic parameters measured just before the end of
reperfusion. Summarized data on peak left ventricular systolic pressure
(LVSP) (A) and maximal positive rate of the first derivative of left
ventricular pressure (dP/dtmax) (B) in the sham-operated wild-type mice
(solid bars) (n  5), tumor necrosis factor (TNF)- knockout (KO) mice
(light bars) (n  5), reperfused wild-type (n  6) and TNF- KO (n 
5) mice. *p  0.05. I/R  ischemia/reperfusion.
Abbreviations and Acronyms
AAR  area at risk
IA  infarct area
ICAM  intercellular adhesion molecule
IL  interleukin
I/R  ischemia/reperfusion
KO  knockout
LV  left ventricle
MCP  monocyte chemoattractant protein
MIP  macrophage inflammatory protein
NF-B  nuclear factor-B
RT-PCR  reverse transcription and polymerase chain
reaction
TNF-  tumor necrosis factor-
WT  wild-type
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inflammatory protein (MIP)-1-, MIP-2 and monocyte
chemoattractant protein (MCP)-1 were investigated. The
fluorescence intensity of each target gene was normalized
with that of -actin amplified under identical conditions.
Histopathological study. The heart embedded in 20°C
cryostat compound (Miles Laboratory, Elkhart, Indiana)
was snap frozen in 2-methylbutane prechilled with liquid
nitrogen and cut into sections 5 m thick. Sections were
stained with May-Giemsa (Muto Pure Chemicals, Tokyo,
Japan). All fields of a midventricular section were observed
at 1,000 magnification, and the number of neutrophils
was counted in a blind fashion. Five sections obtained from
five different mice were examined for each group.
Other sections were stained with goat anti-mouse
TNF- polyclonal antibody (SC-1348; Biotechnology Inc.,
Santa Cruz, California) followed by biotinylated donkey
anti-goat IgG antibody (Biotechnology Inc.). The
streptavidin-peroxidase complex (Dako, Glostrup, Den-
mark) and 3-diaminobenzidine were used for visualization.
Statistical analysis. Results are expressed as mean SEM.
Comparisons between two groups were performed by Stu-
dent t test. Comparisons in the RT-PCR analysis were
performed by two-way analysis of variance, followed by
Scheffe’s post-hoc test. Stat View 5.0 was used for statistical
analyses. Results were considered statistically significant at
p  0.05.
RESULTS
Arrhythmia. The frequency of arrhythmia observed during
reperfusion was significantly less in TNF- KO mice (1.2
0.5 beats/2 h) than in WT mice (31.8  10.1 beats/2 h)
(Fig. 1A). Wild-type mice receiving goat anti-TNF-
antibody showed a reduced frequency of arrhythmia (1.5 
0.4 beats/2 h) compared with those receiving nonimmune
goat IgG (10.8  2.2 beats/2 h) (Fig. 1B). These findings
indicate that TNF- has arrhythmogenic action during
reperfusion.
Hemodynamic study. Peak LV systolic pressure and max-
imal positive rate of dP/dt in TNF- KO mice were
significantly higher than in WT mice during reperfusion
(Fig. 2), whereas no significant differences were observed
between the sham-operated WT and sham-operated
TNF- KO.
Infarct size. Left coronary artery occlusion caused a con-
sistently large ischemic area (AAR). The AAR to LV ratio
Figure 3. Infarct area (IA) and area at risk (AAR) of the left ventricle (LV) after 30-min ligation and 120-min reperfusion. Representative photographs
of midventricular myocardium from wild-type mice (A), tumor necrosis factor (TNF)- knockout (KO) mice (B), wild-type mice receiving nonimmune
IgG (C) and wild-type mice receiving anti-TNF- antibody (D). (E) Summarized data on infarct area to area at risk ratio (IA/AAR), IA to left ventricle
ratio (IA/LV) and AAR to LV ratio (AAR/LV) in wild-type (n  11) and TNF- KO (n  9) mice. (F) Summarized data on IA/AAR, IA/LV and
AAR/LV in wild-type mice receiving nonimmune IgG (n  5) and anti-TNF- antibody (n  5). **p  0.01.
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in TNF- KO mice (60.8  3.0%) did not differ from that
in WT mice (59.6  4.2%) (Fig. 3E). The IA to AAR and
the IA to LV ratios of TNF- KO mice (27.6  2.6% and
17.0  1.8%, respectively) were significantly decreased
compared with those of WT mice (48.5 4.6% and 28.2
234%, respectively) (Fig. 3E). Intravenous injection of
anti-TNF- antibody significantly improved the IA to
AAR ratio (55.4 2.6% vs. 26.1 2.5%) and the IA to LV
ratio (32.8  2.1% vs. 15.0  0.8%) (Fig. 3F).
Electrophoretic gel mobility shift assay. Figure 4A shows
representative results of electrophoretic gel mobility shift
assay for NF-B. Deoxyribonucleic acid binding activity of
NF-B was significantly decreased in TNF- KO mice
(65.1  9.5%), compared with WT mice (100.4  3.5%)
(Fig. 4B).
Measurements of mRNA expression by RT-PCR. In
WT mice, levels of TNF- and IL-6 expression in the
ischemic area were significantly higher than those in the
nonischemic area (Figs. 5A and 5B). Reperfusion-induced
ICAM-1, MIP-2 and MCP-1 expressions were signifi-
cantly suppressed in TNF- KO mice (Figs. 5C to 5F),
indicating that reperfusion-induced expression of these
molecules was mediated at least partly by TNF-.
Immunoreactivity to TNF-. Tumor necrosis factor-
immunoreactivity was detected in the ischemic myocardium
but hardly detected in the nonischemic myocardium (data
not shown). Tumor necrosis factor- immunoreactivity was
also detected in infiltrating leukocytes and endothelial cells
(Fig. 6). Tumor necrosis factor- staining was done on WT
mice.
Counts of infiltrating neutrophils. The neutrophil infil-
tration was observed in the reperfused myocardium. Neu-
trophils were located mainly in the perivascular area of the
border zone. The number of infiltrating neutrophils in WT
mice (421 11, n 5) was significantly (p 0.029) greater
than that in TNF- KO mice (268  56, n  5).
DISCUSSION
TNF- and myocardial reperfusion. Numerous studies
have demonstrated that reperfusion accelerates leukocyte
infiltration of the infarcted myocardium (1). Neutrophil
transendothelial migration and adhesion to cardiac myo-
cytes are mediated mainly by the interaction between
neutrophil Mac-1 (CD11b/CD18) and ICAM-1 expressed
on endothelial cells and cardiac myocytes. This interaction
induces a neutrophil respiratory burst, which causes myocyte
injury via reactive oxygen species (8). In fact, anti-CD11b or
-CD18 antibodies have been shown to have protective
effects against I/R injury (9), and CD18 or ICAM-1 KO
mice show reduced infarct size in I/R injury (10).
Postischemic cardiac lymph can induce ICAM-1 (11)
and IL-6 (2) expressions, which are inhibited by anti-
TNF- antibody (2). Chemokines such as IL-8 and
MCP-1, which are induced by TNF-, mediate the che-
motaxis of neutrophils (12) and monocytes (13) to the
reperfused myocardium. Thus, TNF- might be an up-
stream cytokine initiating the reperfusion-dependent cyto-
kine cascade that induces the expression of adhesion mole-
cules and chemokines (14).
In this study, the frequency of arrhythmia (Fig. 1),
hemodynamic parameters (Fig. 2) and infarct size (Fig. 3)
were significantly improved in TNF- KO mice, compared
with WT mice. Anti-TNF- antibody also reduced the
frequency of arrhythmia (Fig. 1) and infarct size (Fig. 3)
significantly. These observations indicate that TNF- has
detrimental actions during reperfusion.
The role of TNF- in reperfusion-induced NF-B
activation. Nuclear factor-B is known to be a key tran-
scription factor that regulates the expression of inflamma-
tory cytokines, chemokines and adhesion molecules (15).
Nuclear factor-B decoy oligonucleotides block the expres-
sion of IL-6 and ICAM-1 mRNA during reperfusion (3)
and relieve myocardial I/R injury (7). Tumor necrosis
factor- has been reported to activate NF-B in endothelial
cells and cardiac myocytes (7). As oxidative stress itself can
activate NF-B (15), the role of TNF- in reperfusion-
induced NF-B activation is of interest. In the electro-
phoretic gel mobility shift assay for NF-B activation
performed here, DNA binding activity of NF-B during
reperfusion was significantly decreased in TNF- KO mice,
compared with WT mice (Fig. 4), suggesting that
reperfusion-induced NF-B activation is mediated at least
partly by TNF-. The entire LV of the reperfused heart was
Figure 4. Electrophoretic gel mobility shift assay for activation of nuclear
factor-B (NF-B). (A) Representative photographs. Lane 1  reperfused
myocardium from wild-type mice; lane 2  reperfused myocardium from
tumor necrosis factor (TNF)- knockout (KO) mice; lane 3  reperfused
myocardium from wild-type mice with competitive oligonucleotides. (B)
Summarized data on activation of NF-B in wild-type mice (n  5) and
TNF- KO mice (n  5). *p  0.01.
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used instead of the reperfused region to obtain enough
nuclear extract for NF-B analysis; this is considered to be
one of the reasons the difference in NF-B activation
between TNF- KO mice and WT mice was relatively
small.
The role of TNF- in reperfusion-induced expression of
ICAM-1 and chemokines. Tumor necrosis factor- was
expressed at higher levels in the ischemic area than in the
nonischemic area (Fig. 5A), indicating that I/R induces
TNF- expression in WT mice. As the cytokine induction
caused by acute surgical trauma may obscure the
reperfusion-induced cytokine elevation (16), cytokine ex-
pression was compared between the ischemic and nonisch-
emic areas. The expressions of IL-6, ICAM-1, MIP-1,
MIP-2 and MCP-1 were induced by I/R in WT mice (Figs.
5B to 5F). Interestingly, the induction of MIP-2, which is
a mouse homologue of IL-8, was the most prominent
Figure 5. The results of messenger ribonucleic acid expression in wild-type mice (n  5) and tumor necrosis factor (TNF)- knockout (KO) mice (n 
6) determined by reverse transcription and polymerase chain reaction. (A) TNF- (p 0.007). (B) Interleukin (IL)-6 (p-values for the presence of TNF-,
ischemia and their interaction are 0.118, 0.005 and 0.129, respectively). (C) intercellular adhesion molecule (ICAM)-1 (p  0.008, 0.002 and 0.026,
respectively). (D) macrophage inflammatory protein (MIP)-1 (p  0.144, 0.037 and 0.139, respectively). () MIP-2 (p  0.016, 0.006 and 0.017,
respectively). (F) monocyte chemoattractant protein (MCP)-1 (p  0.009, 0.004 and 0.019, respectively).
Figure 6. Immunostaining of tumor necrosis factor- in the reperfused
myocardium of wild-type mice. Tumor necrosis factor- immunoreactivity
was detected in not only myocytes but also infiltrating leukocytes (arrow
heads) and endothelial cells (arrows) at 1,000 magnification. Bars 
20 m.
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(82-fold higher than in the nonischemic area). However,
the reperfusion-induced expression of these molecules was
significantly suppressed in TNF- KO mice, indicating that
this expression was mediated at least partly by TNF-.
These molecules are thought to play important roles in
leukocyte recruitment. In fact, neutrophil infiltration was
significantly suppressed in TNF- KO mice, compared
with WT mice, as expected. Taken together, our findings
indicate that TNF- exacerbates myocardial I/R injury at an
early stage of reperfusion by activating NF-B, thereby
inducing chemokines and adhesion molecules and facilitat-
ing leukocyte infiltration.
Pleiotropic actions of TNF-. Beneficial effects of
TNF- on acute myocardial infarction have been reported
by Kurrelmeyer et al. (5), where TNF- receptor KO mice
showed accelerated myocardial apoptosis and increased
infarct size within 24 h after coronary occlusion without
reperfusion. Tumor necrosis factor- has also been reported
to confer resistance to hypoxic injury in cultured cardiac
myocytes (17). The anti-apoptotic and cytoprotective ac-
tions of TNF- may result from the activation of NF-B
(18), which is mediated by TNF receptor-associated factor
2. Nuclear factor-B activation promotes the expression of
cytoprotective genes, such as manganese superoxide dis-
mutase. Tumor necrosis factor- reduces cardiac contrac-
tility (19). Acute reduction in cardiac contractility does not
necessarily lead to long-term cardiac dysfunction. Tumor
necrosis factor--mediated contractile reduction during
acute ischemia, therefore, may promote cardioprotection by
attenuating the myocardial energy demand. Tumor necrosis
factor- expression is also induced directly by hemodynamic
stress, such as pressure-overload, which elicits cardiac hy-
pertrophy to maintain normal cardiac contractility. This
expression, therefore, is thought to be an adaptive response
to cardiac stress.
In contrast, TNF- can induce apoptosis of cardiac
myocytes and endothelial cells (20). Tumor necrosis factor
receptor p55 and TNF receptor-associated death domain
protein may mediate this signal. Although NF-B mediates
the cardioprotective signals of TNF-, NF-B activation
also induces apoptosis of endothelial cells (7) and the
expressions of chemokines and adhesion molecules (15),
which facilitate leukocyte infiltration. In fact, cardiac-
specific overexpression of TNF- has been reported to cause
severe myocarditis in mice (21). Taken together, it is likely
that TNF- itself has a protective role in cardiac myocytes
during ischemia without reperfusion, but TNF- during
reperfusion facilitates leukocyte infiltration, resulting in
myocardial damage. The difference between the role of
TNF- in ischemia with reperfusion and in ischemia
without reperfusion might depend on the concentration of
TNF- produced by the myocardium (22). Although we
did not compare the level of TNF- during ischemia with
that during reperfusion, the latter may induce a substantial
amount of TNF-. Tumor necrosis factor- could have
both short-term adaptive and long-term maladaptive roles
(23), and even in the acute phase, a high level of TNF-
could have a maladaptive role (22). However, to explore the
mechanism by which reperfusion induces a high level of
TNF- is beyond the scope of this study. As the essential
role of TNF- is promoting innate immunity to eliminate
infectious agents from the host by recruiting leukocytes, the
expression of TNF- during reperfusion is thought to be a
maladaptive response.
Clinical implications and therapeutic potential. Because
TNF- is considered to be involved in the pathogenesis of
various cardiovascular diseases, anti-TNF- strategy may
have therapeutic benefit. In fact, in patients with advanced
heart failure, anti-TNF- therapy using etanercept, a re-
combinant soluble p75 TNF- receptor, showed a signifi-
cant dose-dependent improvement in LV function and
structure (24). As TNF- could play a maladaptive role in
chronic disorders such as heart failure, this outcome met the
expectation. However, the efficacy of the anti-TNF-
therapy in ischemic heart disease is still unclear. Our
findings show that deficiency of TNF- reduced leukocyte
infiltration and ameliorated myocardial I/R injury at an early
stage of reperfusion, which suggests the potential advantage
of anti-TNF- therapy in I/R injury. However, because
TNF- has a cytoprotective action in cardiac myocytes, and
the inflammatory reaction induced by TNF- may facilitate
tissue repair (1), the effects of TNF- deficiency on I/R
injury should be investigated, particularly at the healing
stage.
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